Junyan Lu
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
Papers in
- Genetics 28
- Chronic Lymphocytic Leukemia Research 28
-
- Lymphoma Diagnosis and Treatment 16
- Co-authors
- Cheng Luo (30 shared papers)Hualiang Jiang (17 shared papers)Xiangqian Kong (13 shared papers)Zhongjie T. Liang (9 shared papers)Sisheng Ouyang (5 shared papers)Jing Dong (3 shared papers)Lin Xiang (3 shared papers)Min Liu (1 shared paper)
- Journals
- Blood (9 papers)Leukemia (4 papers)PLoS ONE (4 papers)Nature Cancer (3 papers)Nature Communications (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Junyan Lu
104 papers receiving 3.6k citations
Junyan Lu's Hit Papers
Peers
Comparison fields: 5 of 139
- Genetics 379
- Molecular Biology 2.0k
- Oncology 484
- Cancer Research 260
- Pathology and Forensic Medicine 288
Countries citing papers authored by Junyan Lu
This map shows the geographic impact of Junyan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Lu more than expected).
Fields of papers citing papers by Junyan Lu
This network shows the impact of papers produced by Junyan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Lu. The network helps show where Junyan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junyan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer Hit paper breakdown → | 2020 | 282 |
| 2 | 2012 | 277 | |
| 3 | 2015 | 263 | |
| 4 | 2012 | 260 | |
| 5 | 2015 | 228 | |
| 6 | 2015 | 181 | |
| 7 | 2014 | 181 | |
| 8 | 2017 | 97 | |
| 9 | 2016 | 95 | |
| 10 | 2014 | 93 | |
| 11 | 2021 | 82 | |
| 12 | 2020 | 67 | |
| 13 | 2020 | 60 | |
| 14 | 2015 | 56 | |
| 15 | 2013 | 50 | |
| 16 | 2024 | 48 | |
| 17 | 2022 | 44 | |
| 18 | 2021 | 42 | |
| 19 | 2017 | 41 | |
| 20 | 2014 | 40 |
About Junyan Lu
Junyan Lu is a scholar working on Genetics, Pathology and Forensic Medicine, Molecular Biology, Immunology and Cancer Research, having authored 110 papers that have together received 3.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (16 papers), Epigenetics and DNA Methylation (12 papers), Immunodeficiency and Autoimmune Disorders (9 papers), Cancer-related gene regulation (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Genetics (379 citations), Molecular Biology (2.0k citations), Oncology (484 citations), Cancer Research (260 citations) and Pathology and Forensic Medicine (288 citations). Junyan Lu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Cheng Luo, Hualiang Jiang, Xiangqian Kong, Zhongjie T. Liang, Sisheng Ouyang, Jing Dong, Lin Xiang, Min Liu, Guangda Xiang and Chuan He. Their work appears in journals such as Blood, Leukemia, PLoS ONE, Nature Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.